These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16102450)

  • 21. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OX40 controls islet allograft tolerance in CD154 deficient mice by regulating FOXP3+ Tregs.
    Chen M; Xiao X; Demirci G; Li XC
    Transplantation; 2008 Jun; 85(11):1659-62. PubMed ID: 18551075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
    Kaczmarek I; Deutsch MA; Sadoni S; Brenner P; Schmauss D; Daebritz SH; Weiss M; Meiser BM; Reichart B
    J Heart Lung Transplant; 2007 May; 26(5):511-5. PubMed ID: 17449422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model.
    Jensen JN; Tung TH; Mackinnon SE; Brenner MJ; Hunter DA
    Microsurgery; 2004; 24(4):309-15. PubMed ID: 15274190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survival.
    Fiorina P; Jurewicz M; Tanaka K; Behazin N; Augello A; Vergani A; von Andrian UH; Smith NR; Sayegh MH; Abdi R
    Diabetes; 2007 Apr; 56(4):912-20. PubMed ID: 17287465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microchimerism does not correlate with survival of murine cardiac allografts.
    de Moraes LV; Bueno V; Panajotopoulos N; Rizzo LV
    Transplant Proc; 2004 May; 36(4):1021-2. PubMed ID: 15194355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoptive transfer of double negative T regulatory cells induces B-cell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation.
    Ma Y; He KM; Garcia B; Min W; Jevnikar A; Zhang ZX
    Xenotransplantation; 2008 Feb; 15(1):56-63. PubMed ID: 18333914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allopeptide-pulsed dendritic cells and composite tissue allograft survival.
    Nguyen VT; Taieb A; Sacks JM; Unadkat JV; Clavijo JA; Kim H; Feili-Hariri M; Lee WP
    Microsurgery; 2007; 27(2):105-11. PubMed ID: 17290380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.
    Emmer PM; van der Vlag J; Adema GJ; Hilbrands LB
    Transplantation; 2006 May; 81(10):1451-9. PubMed ID: 16732184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.
    Brennan TV; Hoang V; Garrod KR; Liu FC; Hayden T; Kim J; Kang SM
    Transplantation; 2008 Jan; 85(2):247-55. PubMed ID: 18212630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Divergent role of donor dendritic cells in rejection versus tolerance of allografts.
    Ueno T; Tanaka K; Jurewicz M; Murayama T; Guleria I; Fiorina P; Paez JC; Augello A; Vergani A; Wong M; Smith RN; Abdi R
    J Am Soc Nephrol; 2009 Mar; 20(3):535-44. PubMed ID: 19129312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rapamycin combined with donor bone marrow-derived immature dendritic cells induces mouse skin allograft tolerance].
    Yu S; He X; Hu A; Fu BM; Ma Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):399-402. PubMed ID: 18359700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
    Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
    Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination of CD4+ CD25+ regulatory T cell and costimulatory pathway blockade inhibits acute rejection after liver transplantation: experiment with rats].
    Shi LB; Zhang HW; Peng CH
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):942-6. PubMed ID: 17650415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of CD154 in organ transplant rejection and acceptance.
    Kirk AD; Blair PJ; Tadaki DK; Xu H; Harlan DM
    Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):691-702. PubMed ID: 11375072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.